Sandra Swain, MD, medical director of the Washington Cancer Institute at MedStar Washington Hospital Center, discusses the utility for vinegar as a screening tool in the U.S.
Sandra Swain, MD, medical director of the Washington Cancer Institute at MedStar Washington Hospital Center, discusses the utility for vinegar as a screening tool in the U.S.
In a cluster-randomized study that analyzed 150,000 women in Mumbai, India, vinegar (acetic acid) demonstrated to be an adequate screening tool for cervical cancer.
Swain believes that the use of vinegar as a screening tool has a greater implication in developing countries with no resources and probably will not be adopted in the U.S.
A recent study found that a DNA test was superior to vinegar, though screening was only done once. In the Mumbai study, screening was done four times every two years. The idea of an inexpensive DNA test is being examined, Swain says.
Advancing Neoadjuvant Therapy for HER2+ Breast Cancer Through ctDNA Monitoring
December 19th 2024In an interview with Targeted Oncology, Adrienne Waks, MD, provided insights into the significance of the findings from the DAPHNe trial and their clinical implications for patients with HER2-positive breast cancer.
Read More
Systemic Therapy Choice Linked to Radiosurgery Outcomes in Brain Mets
December 6th 2024In an interview with Targeted OncologyT, Rupesh Kotecha, MD, discussed a study focused on how systemic therapy selection impacts outcomes in patients with brain metastases, particularly those with lung cancer.
Read More